289 related articles for article (PubMed ID: 12559661)
1. Atypical antipsychotic drugs improve cognition in schizophrenia.
Meltzer HY; Sumiyoshi T
Biol Psychiatry; 2003 Feb; 53(3):265-7; author reply 267-8. PubMed ID: 12559661
[No Abstract] [Full Text] [Related]
2. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
Addington J; Addington D
Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073
[No Abstract] [Full Text] [Related]
3. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
Purdon SE; Jones BD; Stip E; Labelle A; Addington D; David SR; Breier A; Tollefson GD
Arch Gen Psychiatry; 2000 Mar; 57(3):249-58. PubMed ID: 10711911
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
Weiss E; Kemmler G; Fleischhacker WW
Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
[No Abstract] [Full Text] [Related]
5. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
[TBL] [Abstract][Full Text] [Related]
6. The effect of risperidone on cognition in patients with schizophrenia.
Stip E; Lussier I
Can J Psychiatry; 1996 Oct; 41(8 Suppl 2):S35-40. PubMed ID: 8899249
[TBL] [Abstract][Full Text] [Related]
7. Risperidone: efficacy and safety.
Umbricht D; Kane JM
Schizophr Bull; 1995; 21(4):593-606. PubMed ID: 8749887
[TBL] [Abstract][Full Text] [Related]
8. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.
Harvey PD; Patterson TL; Potter LS; Zhong K; Brecher M
Am J Psychiatry; 2006 Nov; 163(11):1918-25. PubMed ID: 17074943
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
[TBL] [Abstract][Full Text] [Related]
10. [Neuroleptics and cognition].
Brunnauer A; Geiger E; Laux G
Psychiatr Prax; 2003 May; 30 Suppl 2():S106-9. PubMed ID: 14509053
[TBL] [Abstract][Full Text] [Related]
11. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
Dittert S; Soyka M; Winter C; Möller HJ
Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
[No Abstract] [Full Text] [Related]
12. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
[TBL] [Abstract][Full Text] [Related]
13. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Heinrichs RW
Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
[No Abstract] [Full Text] [Related]
14. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Jockers-Scherübl MC; Kühn KU; Lemke M; Bechdolf A; Bender S; Degner D; Schlösser R; Schmidt LG; Schmitt A; Jäger M; Buchkremer G; Falkai P; Klingberg S; Köpcke W; Maier W; Häfner H; Ohmann C; Salize HJ; Schneider F; Möller HJ;
J Clin Psychiatry; 2007 Nov; 68(11):1763-74. PubMed ID: 18052570
[TBL] [Abstract][Full Text] [Related]
15. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics and cognition in schizophrenia.
Sharma T
Arch Gen Psychiatry; 2002 Jun; 59(6):571-2; author reply 573-5. PubMed ID: 12044209
[No Abstract] [Full Text] [Related]
18. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
19. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
20. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol.
Sergi MJ; Green MF; Widmark C; Reist C; Erhart S; Braff DL; Kee KS; Marder SR; Mintz J
Am J Psychiatry; 2007 Oct; 164(10):1585-92. PubMed ID: 17898351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
